Dual HDAC/BRD4 inhibitors against cancer
Crossref DOI link: https://doi.org/10.1007/s00044-021-02776-9
Published Online: 2021-08-14
Published Print: 2021-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Omidkhah, Negar
Hadizadeh, Farzin
Ghodsi, Razieh
Text and Data Mining valid from 2021-08-14
Version of Record valid from 2021-08-14
Article History
Received: 2 May 2021
Accepted: 26 July 2021
First Online: 14 August 2021
Compliance with ethical standards
:
: The authors declare no competing interests.